Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

Rhea-AI Summary

Axogen (Nasdaq: AXGN) management will participate in three investor conferences in early March 2026: Raymond James (presentation), Leerink Global Healthcare (fireside chat) and Citizens Life Sciences (fireside chat).

Presentations are scheduled March 3, March 9, and March 10, 2026; webcasts and 90-day replays are available via the company's Investors page at www.axogeninc.com.

ALACHUA, Fla. and TAMPA, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences:

Raymond James 47th Annual Institutional Investors Conference
Participation: Presentation and 1x1 investor meetings
Date/Time: Presentation Tuesday, March 3, 2026, 3:25 PM ET
Webcast Link: Raymond James/Axogen Presentation

Leerink Global Healthcare Conference
Participation: Fireside Chat and 1x1 investor meetings
Date/Time: Fireside Chat Monday, March 9, 2026, 1:00 PM ET
Webcast Link: Leerink/Axogen Fireside Chat

The Citizens Life Sciences Conference
Participation: Fireside Chat and 1x1 investor meetings
Date/Time: Fireside Chat Tuesday, March 10, 2026, 12:30 PM ET
Webcast Link: Citizens/Axogen Fireside Chat

Webcast events can be accessed live through the Investors page at www.axogeninc.com. For those unable to listen to the live broadcast, the replay will be archived for 90 days and available on the Investors page at www.axogeninc.com.

About Axogen

Axogen (Nasdaq: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve repair. With a mission to make nerve repair the expected standard of care, Axogen advances the field through research, education, and collaboration with surgeons and healthcare providers across a global network.

Axogen’s product portfolio includes Avance® (acellular nerve allograft-arwx), Avance® Nerve Graft, Axoguard Nerve Connector®, Axoguard Nerve Protector®, Axoguard HA+ Nerve Protector™, Axoguard Nerve Cap®, and Avive+ Soft Tissue Matrix™.​

Contact:
Axogen, Inc.
InvestorRelations@axogeninc.com

FAQ

When will Axogen (AXGN) present at the Raymond James conference in 2026?

Axogen will present on Tuesday, March 3, 2026 at 3:25 PM ET. According to the company, the session includes a presentation and 1x1 investor meetings and will be webcast from the Raymond James event.

How can investors watch Axogen's (AXGN) Leerink Global Healthcare fireside chat on March 9, 2026?

Investors can watch the Leerink fireside chat live via webcast on the company's Investors page. According to the company, the fireside chat is scheduled for Monday, March 9, 2026 at 1:00 PM ET with 1x1 meetings also planned.

What is Axogen's (AXGN) schedule at the Citizens Life Sciences Conference in March 2026?

Axogen will hold a fireside chat on Tuesday, March 10, 2026 at 12:30 PM ET. According to the company, management will also conduct 1x1 investor meetings and the event will be webcast.

Where will Axogen (AXGN) host the webcasts and how long will replays be available?

Webcasts will be hosted on Axogen's Investors page at www.axogeninc.com, with replays archived for 90 days. According to the company, live access and replay availability are provided for each conference presentation.

Will Axogen (AXGN) hold investor meetings around the March 2026 conference appearances?

Yes, Axogen management plans 1x1 investor meetings alongside presentations and fireside chats. According to the company, these meetings accompany the Raymond James, Leerink, and Citizens conference appearances in early March 2026.